Tsutomu Mimoto

1.1k total citations
20 papers, 878 citations indexed

About

Tsutomu Mimoto is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Tsutomu Mimoto has authored 20 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Virology and 11 papers in Molecular Biology. Recurrent topics in Tsutomu Mimoto's work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (12 papers) and Chemical Synthesis and Analysis (8 papers). Tsutomu Mimoto is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (12 papers) and Chemical Synthesis and Analysis (8 papers). Tsutomu Mimoto collaborates with scholars based in Japan, United States and Italy. Tsutomu Mimoto's co-authors include Yoshiaki Kiso, Kenichi Akaji, Naoko Hattori, John W. Erickson, Junya Imai, Sergei Gulnik, Makoto Shintani, Hideya Hayashi, Hiroshi Enomoto and Hiroaki Mitsuya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tsutomu Mimoto

20 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tsutomu Mimoto Japan	13	475	427	388	325	129	20	878
Sally Redshaw United Kingdom	11	715 1.5×	503 1.2×	594 1.5×	376 1.2×	162 1.3×	26	1.3k
James A. Nieman Canada	18	293 0.6×	392 0.9×	217 0.6×	448 1.4×	108 0.8×	28	1.1k
James P. Guare United States	14	432 0.9×	425 1.0×	369 1.0×	546 1.7×	67 0.5×	32	1.1k
Björn Classon Sweden	21	370 0.8×	727 1.7×	201 0.5×	763 2.3×	124 1.0×	67	1.3k
Linda S. Payne United States	12	453 1.0×	520 1.2×	359 0.9×	429 1.3×	87 0.7×	19	1.1k
Marlene M. Rayner United States	14	597 1.3×	590 1.4×	533 1.4×	527 1.6×	214 1.7×	19	1.3k
Antonin Kröhn United Kingdom	7	647 1.4×	461 1.1×	540 1.4×	307 0.9×	118 0.9×	9	1.1k
Rhonda B. Levin United States	9	527 1.1×	428 1.0×	405 1.0×	425 1.3×	159 1.2×	9	1.1k
Maha Kosa United States	6	282 0.6×	284 0.7×	170 0.4×	315 1.0×	98 0.8×	9	837
Khaja Azhar Hussain United States	12	290 0.6×	360 0.8×	250 0.6×	369 1.1×	155 1.2×	17	833

Countries citing papers authored by Tsutomu Mimoto

Since Specialization

Citations

This map shows the geographic impact of Tsutomu Mimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsutomu Mimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsutomu Mimoto more than expected).

Fields of papers citing papers by Tsutomu Mimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsutomu Mimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsutomu Mimoto. The network helps show where Tsutomu Mimoto may publish in the future.

Co-authorship network of co-authors of Tsutomu Mimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Tsutomu Mimoto. A scholar is included among the top collaborators of Tsutomu Mimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsutomu Mimoto. Tsutomu Mimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Daisuke, et al.. (2010). A Practical Use of Ligand Efficiency Indices Out of the Fragment-Based Approach: Ligand Efficiency-Guided Lead Identification of Soluble Epoxide Hydrolase Inhibitors. Journal of Medicinal Chemistry. 54(3). 851–857. 60 indexed citations

Mimoto, Tsutomu, et al.. (2007). Structure–activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure. Bioorganic & Medicinal Chemistry. 16(3). 1299–1308. 9 indexed citations

Mimoto, Tsutomu, Satoshi Nojima, Haruo Takaku, et al.. (2003). Structure–activity and structure–metabolism relationships of HIV protease inhibitors containing the 3-hydroxy-2-methylbenzoyl-allophenylnorstatine structure. Bioorganic & Medicinal Chemistry. 12(1). 281–293. 23 indexed citations

Doi, Mitsunobu, Toshimasa Ishida, Yoshio Katsuya, et al.. (2001). KNI-272, a highly selective and potent peptidic HIV protease inhibitor. Acta Crystallographica Section C Crystal Structure Communications. 57(11). 1333–1335. 4 indexed citations

Mimoto, Tsutomu, Naoko Hattori, Haruo Takaku, et al.. (2000). Structure-Activity Relationship of Orally Potent Tripeptide-Based HIV Protease Inhibitors Containing Hydroxymethylcarbonyl Isostere.. Chemical and Pharmaceutical Bulletin. 48(9). 1310–1326. 37 indexed citations

Mahfouz, Nadia M., et al.. (2000). Synthesis of di- and tripeptide analogues containing α-ketoamide as a new core structure for inhibition of HIV-1 protease. European Journal of Medicinal Chemistry. 35(10). 887–894. 62 indexed citations

Yoshimura, Kazuhisa, Ryohei Kato, Keisuke Yusa, et al.. (1999). JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proceedings of the National Academy of Sciences. 96(15). 8675–8680. 87 indexed citations

Mimoto, Tsutomu, Ryohei Kato, Haruo Takaku, et al.. (1999). Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing Allophenylnorstatine. Journal of Medicinal Chemistry. 42(10). 1789–1802. 60 indexed citations

Kiso, Yoshiaki, Satoshi Yamaguchi, Hikaru Matsumoto, et al.. (1998). KNI-577, a Potent Small-Sized HIV Protease Inhibitor Based on the Dipeptide Containing the Hydroxymethylcarbonyl Isostere as an Ideal Transition-State Mimic. Archiv der Pharmazie. 331(3). 87–89. 24 indexed citations

10.

Baldwin, Eric T., Talapady N. Bhat, Sergei Gulnik, et al.. (1995). Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine. Structure. 3(6). 581–590. 127 indexed citations

11.

Kiriyama, Akiko, et al.. (1993). Comparison of a new orally potent tripeptide HIV‐1 protease inhibitor (anti‐aids drug) based on pharmacokinetic characteristics in rats after intravenous and intraduodenal administrations. Biopharmaceutics & Drug Disposition. 14(8). 697–707. 12 indexed citations

12.

Kiriyama, Akiko, Tsutomu Mimoto, Yoshiaki Kiso, & Kanji Takada. (1993). Pharmacokinetic study of a tripeptide HIV‐1 protease inhibitor, KNI‐174, in rats after intravenous and intraduodenal administrations. Biopharmaceutics & Drug Disposition. 14(3). 199–207. 12 indexed citations

13.

Kageyama, Seiji, Tsutomu Mimoto, Motoyoshi Nomizu, et al.. (1993). In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Antimicrobial Agents and Chemotherapy. 37(4). 810–817. 91 indexed citations

14.

Saji, Hideo, Yoshiaki Kiso, Tsutomu Mimoto, et al.. (1992). Synthesis and biological evaluation of a 13N-labeled opioid peptide. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(4). 455–460. 3 indexed citations

15.

Mimoto, Tsutomu, Junya Imai, Hiroshi Enomoto, et al.. (1992). Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.. Chemical and Pharmaceutical Bulletin. 40(8). 2251–2253. 122 indexed citations

16.

Kiso, Yoshiaki, Shin Iinuma, Tsutomu Mimoto, et al.. (1991). A Synthetic Method Suitable for the Rapid Preparation of 13N-Labeled Dermorphin Analogue, H-Tyr-D-Met(O)-Phe-Gly-NH2 (SD-62).. Chemical and Pharmaceutical Bulletin. 39(10). 2734–2736. 1 indexed citations

17.

Mimoto, Tsutomu, Junya Imai, Naoko Hattori, et al.. (1991). Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic.. Chemical and Pharmaceutical Bulletin. 39(9). 2465–2467. 64 indexed citations

18.

Mimoto, Tsutomu, Junta Imai, Senku Tanaka, et al.. (1991). KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.. Chemical and Pharmaceutical Bulletin. 39(11). 3088–3090. 69 indexed citations

19.

Kiso, Yoshiaki, Tooru Kimura, Makoto Yoshida, et al.. (1989). A new class of amino protecting group removable by reductive acidolysis: the 4-methylsulphinylbenzyloxycarbonyl (Msz) group. Journal of the Chemical Society Chemical Communications. 1511–1511. 10 indexed citations

20.

Saji, Hideo, et al.. (1989). Synthesis and in vivo evaluation of N‐13 labeled opioid peptide analogue for PET opiate receptor studies. Journal of Labelled Compounds and Radiopharmaceuticals. 26(1-12). 73–75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact